Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. | Cancers (Basel) | 2022 | 35205765 | PubTator, text mining | PubMed |
| Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. | Cancers (Basel) | 2022 | 35205758 | PubTator, text mining | PubMed |
| Milk-Derived Proteins and Peptides in Head and Neck Carcinoma Treatment. | Biomolecules | 2022 | 35204791 | PubTator, text mining | PubMed |
| Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression. | Biomedicines | 2022 | 35203511 | PubTator, text mining | PubMed |
High Precision Use of Botulinum Toxin Type A (BONT-A) in Aesthetics Based on Muscle Atrophy, Is Muscular Architecture Reprogramming a Possibility? A Systematic Review of Literature on Muscle Atrophy after BoNT-A Injections. | Toxins (Basel) | 2022 | 35202109 | PubTator, text mining | PubMed |
| Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype. | J Neuropathol Exp Neurol | 2022 | 35190826 | PubTator, text mining | PubMed |
| Tcf1 preprograms the mobilization of glycolysis in central memory CD8+ T cells during recall responses. | Nat Immunol | 2022 | 35190717 | PubTator, text mining | PubMed |
| Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. | Mol Cancer | 2022 | 35189910 | PubTator, text mining | PubMed |
| SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells. | Int J Mol Sci | 2022 | 35163229 | PubTator, text mining | PubMed |
| A Single-Cell Omics Network Model of Cell Crosstalk during the Formation of Primordial Follicles. | Cells | 2022 | 35159142 | PubTator, text mining | PubMed |
| Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. | Cancers (Basel) | 2022 | 35158821 | PubTator, text mining | PubMed |
| Single-cell dissection of the human brain vasculature. | Nature | 2022 | 35158371 | PubTator, text mining | PubMed |
| Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients. | Oncoimmunology | 2022 | 35154905 | PubTator, text mining | PubMed |
| Novel Insights into the Stemness and Immune Privilege of Mesenchymal Stem Cells from Human Wharton Jelly by Single-Cell RNA Sequencing. | Med Sci Monit | 2022 | 35153292 | PubTator, text mining | PubMed |
| Suppression of tumor metastasis by a RECK-activating small molecule. | Sci Rep | 2022 | 35149728 | PubTator, text mining | PubMed |
| ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation. | Sci Rep | 2022 | 35149717 | PubTator, text mining | PubMed |
| Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection. | Sci Immunol | 2022 | 35148200 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Human embryoid bodies as a novel system for genomic studies of functionally diverse cell types. | Elife | 2022 | 35142607 | PubTator, text mining | PubMed |
| Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease. | Inflamm Regen | 2022 | 35130955 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=37